MYLAN KOHLER: Open Payments
NPI 1457521866 · DE PERE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,885 in 181 payments from 15 companies in 2025. Trend: 2023 $3,700 · 2024 $2,522 · 2025 $2,885
Food & beverage: $2,872Education: $13
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 37 | $667 |
| E.R. Squibb & Sons, L.L.C. | 16 | $365 |
| Supernus Pharmaceuticals, Inc. | 38 | $295 |
| Alkermes, Inc. | 18 | $260 |
| Collegium Pharmaceutical, Inc. | 15 | $241 |
| Otsuka America Pharmaceutical, Inc. | 7 | $190 |
| Neurocrine BioSciences, Inc. | 10 | $178 |
| Axsome Therapeutics, Inc. | 13 | $155 |
| Lundbeck LLC | 9 | $146 |
| Teva Pharmaceuticals USA, Inc. | 1 | $119 |
Products named: FANAPT, COBENFY, Qelbree, Jornay PM, REXULTI, INGREZZA, ARISTADA, Auvelity.
Industry payments across WI — which companies pay providers there.
